Antecedent Metabolic Health and Metformin (ANTHEM) Aging Study: Rationale and Study Design for a Randomized Controlled Trial is a research paper published in The Journals of Gerontology Series A (2021). On theSindex it has a DataRank of 0.752. It has been cited 15 times, with 14 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.416
From this paper's citation signal
Citation Network Contribution
0.336
From 12 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 14 citers.
National Institute on Aging
Grant: R01 AG064951
National Center for Advancing Translational Sciences
Grant: UL1TR002373
Oklahoma Shared Clinical and Translational Resources
Grant: U54GM104938
NIA NIH HHS
Grant: T32 AG052363
BLRD VA
Grant: I01 BX005592
National Institutes of Health
Grant: 2UL1TR002373-06
University of Wisconsin Institute for Clinical and Translational Research
National Institutes of Health
Grant: 1R01AG064951-01
Does insulin sensitivity impact the potential of metformin to slow aging?
National Institutes of Health
Grant: 5U54GM104938-07
Oklahoma Shared Clinical and Translational Resources
NIH
FWCI
0.67
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals